These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30692879)

  • 1. Precarity, clinical labour and graduation from Ebola clinical research in West Africa.
    Alenichev A; Nguyen VK
    Glob Bioeth; 2019; 30(1):1-18. PubMed ID: 30692879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conceptions within misconceptions: Pluralisms in an Ebola vaccine trial in West Africa.
    Alenichev A; Peeters Grietens K; Gerrets R
    Glob Public Health; 2020 Jan; 15(1):13-21. PubMed ID: 31237180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
    Lhomme E; Modet C; Augier A; Faye S; Dabakuyo-Yonli TS; Levy-Marchal C; D'Ortenzio E; Yazdanpanah Y; Chêne G; Beavogui AH; Richert L;
    Trials; 2019 Jul; 20(1):422. PubMed ID: 31296253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
    Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics of trial drug use: to give or not to give?
    Ebunoluwa OO; Kareem FA
    BEOnline; 2016; 3(2):22-40. PubMed ID: 28367458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial.
    Tengbeh AF; Enria L; Smout E; Mooney T; Callaghan M; Ishola D; Leigh B; Watson-Jones D; Greenwood B; Larson H; Lees S
    Soc Sci Med; 2018 Apr; 203():35-42. PubMed ID: 29544144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics, human rights and HIV vaccine trials in low-income settings.
    London L; Kagee A; Moodley K; Swartz L
    J Med Ethics; 2012 May; 38(5):286-93. PubMed ID: 22147744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The change-makers of West Africa.
    Godt S; Mhatre S; Schryer-Roy AM
    Health Res Policy Syst; 2017 Jul; 15(Suppl 1):52. PubMed ID: 28722548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participant views and experiences of participating in HIV research in sub-Saharan Africa: a qualitative systematic review.
    Nalubega S; Evans C
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):330-420. PubMed ID: 26455613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.
    Higgs ES; Dubey SA; Coller BAG; Simon JK; Bollinger L; Sorenson RA; Wilson B; Nason MC; Hensley LE
    Curr Top Microbiol Immunol; 2017; 411():229-261. PubMed ID: 28918539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.
    Mooney T; Smout E; Leigh B; Greenwood B; Enria L; Ishola D; Manno D; Samai M; Douoguih M; Watson-Jones D
    Clin Trials; 2018 Oct; 15(5):436-443. PubMed ID: 29895178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial.
    Li JX; Hou LH; Meng FY; Wu SP; Hu YM; Liang Q; Chu K; Zhang Z; Xu JJ; Tang R; Wang WJ; Liu P; Hu JL; Luo L; Jiang R; Zhu FC; Chen W
    Lancet Glob Health; 2017 Mar; 5(3):e324-e334. PubMed ID: 28017642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical considerations in the conduct of research on therapies for the prevention and treatment of Ebola virus disease in developing countries.
    Folayan MO; Haire BG
    Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):8. PubMed ID: 26740837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.
    Tarimo EA; Bakari M; Kakoko DC; Kohi TW; Mhalu F; Sandstrom E; Kulane A
    BMC Public Health; 2016 Feb; 16():182. PubMed ID: 26911203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection Prevention and Control for Ebola in Health Care Settings - West Africa and United States.
    Hageman JC; Hazim C; Wilson K; Malpiedi P; Gupta N; Bennett S; Kolwaite A; Tumpey A; Brinsley-Rainisch K; Christensen B; Gould C; Fisher A; Jhung M; Hamilton D; Moran K; Delaney L; Dowell C; Bell M; Srinivasan A; Schaefer M; Fagan R; Adrien N; Chea N; Park BJ
    MMWR Suppl; 2016 Jul; 65(3):50-6. PubMed ID: 27390018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical challenges experienced by UK military medical personnel deployed to Sierra Leone (operation GRITROCK) during the 2014-2015 Ebola outbreak: a qualitative study.
    Draper H; Jenkins S
    BMC Med Ethics; 2017 Dec; 18(1):77. PubMed ID: 29258519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
    Kibuuka H; Berkowitz NM; Millard M; Enama ME; Tindikahwa A; Sekiziyivu AB; Costner P; Sitar S; Glover D; Hu Z; Joshi G; Stanley D; Kunchai M; Eller LA; Bailer RT; Koup RA; Nabel GJ; Mascola JR; Sullivan NJ; Graham BS; Roederer M; Michael NL; Robb ML; Ledgerwood JE;
    Lancet; 2015 Apr; 385(9977):1545-54. PubMed ID: 25540891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic.
    Shah SK; Wendler D; Danis M
    Am J Bioeth; 2015; 15(4):11-6. PubMed ID: 25856592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Response to and Impact of the Ebola Epidemic: Towards an Agenda for Interdisciplinary Research.
    Calnan M; Gadsby EW; Kondé MK; Diallo A; Rossman JS
    Int J Health Policy Manag; 2018 May; 7(5):402-411. PubMed ID: 29764104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.
    Kennedy SB; Neaton JD; Lane HC; Kieh MW; Massaquoi MB; Touchette NA; Nason MC; Follmann DA; Boley FK; Johnson MP; Larson G; Kateh FN; Nyenswah TG
    Clin Trials; 2016 Feb; 13(1):49-56. PubMed ID: 26768572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.